Masimo Corp. Sets New 1-Year High at $31.68 (MASI)
Shares of Masimo Corp. (NASDAQ:MASI) hit a new 52-week high during trading hours on Tuesday, Stock Ratings News reports. The company traded as high as $31.68 and last traded at $31.56, with a volume of 216,879 shares trading hands. The stock had previously closed at $31.15.
Several analysts have recently commented on the stock. Analysts at Roth Capital raised their price target on shares of Masimo Corp. from $29.00 to $32.00 in a research note to investors on Thursday, October 31st. They now have a “buy” rating on the stock. Separately, analysts at Feltl & Co. raised their price target on shares of Masimo Corp. from $22.00 to $26.00 in a research note to investors on Thursday, October 31st. They now have a “hold” rating on the stock. They noted that the move was a valuation call. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Masimo Corp. in a research note to investors on Thursday, October 31st. They now have a $30.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Masimo Corp. currently has a consensus rating of “Buy” and a consensus price target of $28.00.
Masimo Corp. has a 52 week low of $19.03 and a 52 week high of $31.68. The stock’s 50-day moving average is $29.52 and its 200-day moving average is $26.86. The company has a market cap of $1.784 billion and a price-to-earnings ratio of 28.06.
Masimo Corp. (NASDAQ:MASI) last announced its earnings results on Wednesday, October 30th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.01. The company had revenue of $131.40 million for the quarter, compared to the consensus estimate of $132.47 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 10.3% on a year-over-year basis. On average, analysts predict that Masimo Corp. will post $1.16 earnings per share for the current fiscal year.
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.